Association of human leukocyte A, B, and DR antigens in Colombian patients with diagnosis of spondyloarthritis
- PMID: 28013432
- DOI: 10.1007/s10067-016-3516-2
Association of human leukocyte A, B, and DR antigens in Colombian patients with diagnosis of spondyloarthritis
Abstract
There is substantial evidence that non-B27 major histocompatibility complex (MHC) genes are associated with spondyloarthritis (SpA). Studies in Mexican and Tunisian populations demonstrated the association of SpA and human leukocyte antigen (HLA) B15. The purpose of this study was to evaluate the association of HLA-A, B, and DR antigens in a group of Colombian patients with a diagnosis of SpA. A total of 189 patients and 100 healthy subjects were included in the present study. All subjects underwent a complete characterization of HLA alleles A, B, and DR. Of the 189 studied patients, 35 were reactive arthritis (ReA), 87 were ankylosing spondylitis (AS), and 67 undifferentiated SpA (uSpA). According to the Assessment of Spondyloarthritis International Society (ASAS) criteria, 167 were axial SpA (axSpA) and 171 were peripheral SpA (pSpA). 63.8% were men, with a mean age of 35.9 ± 12.7 years. 40.7% (77/189) of patients were HLA-B27 positive of which 52.9% had AS and 42.5% axSpA. 23.2% (44/189) of patients were HLA-B15 positive: 23.8% were uSpA, 12.57% were axSpA, and 11.7% were pSpA. In addition, HLA-DRB1*01 was associated with AS (58.6%) and axSpA (42.5%). Also, HLA-DRB1*04 was present in 62 patients with AS (71.2%) and in 26 with axSpA (15.5%). In this population, we found a strong association between the presence of HLA-B27 and the diagnosis of axSpA and AS, but the HLA-B15 is also significantly associated with all subtypes of the disease, predominantly with pSpA. Additionally, HLA-DR1 and DR4 were associated in a cohort of patients with SpA from Colombia.
Keywords: Allele frequency; Colombia; Genetics; HLA-B15; Humans; Spondyloarthritis.
Similar articles
-
Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns.BMJ Open. 2015 Nov 11;5(11):e009092. doi: 10.1136/bmjopen-2015-009092. BMJ Open. 2015. PMID: 26560062 Free PMC article.
-
Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients.Ann Rheum Dis. 2002 Aug;61(8):714-7. doi: 10.1136/ard.61.8.714. Ann Rheum Dis. 2002. PMID: 12117677 Free PMC article.
-
MHC class I and class II genes in Tunisian patients with reactive and undifferentiated arthritis.Clin Exp Rheumatol. 2009 Mar-Apr;27(2):208-13. Clin Exp Rheumatol. 2009. PMID: 19473559
-
Spondyloarthritis in sub-Saharan Africa.Curr Rheumatol Rep. 2014 Jun;16(6):421. doi: 10.1007/s11926-014-0421-z. Curr Rheumatol Rep. 2014. PMID: 24744085 Review.
-
Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?Rom J Ophthalmol. 2018 Apr-Jun;62(2):114-122. Rom J Ophthalmol. 2018. PMID: 30206554 Free PMC article. Review.
Cited by
-
Exploring the Pathogenesis of Spondylarthritis beyond HLA-B27: A Descriptive Review.Int J Mol Sci. 2024 May 31;25(11):6081. doi: 10.3390/ijms25116081. Int J Mol Sci. 2024. PMID: 38892265 Free PMC article. Review.
-
Expanding the Genetic Framework: Insights into Non-HLA-B27 Contributions to Axial Spondylarthritis.Medicina (Kaunas). 2025 Apr 25;61(5):793. doi: 10.3390/medicina61050793. Medicina (Kaunas). 2025. PMID: 40428751 Free PMC article.
-
Genetic Complexity in Spondyloarthritis: Contributions of HLA-B Alleles Beyond HLA-B*27 in Romanian Patients.Int J Mol Sci. 2025 Aug 6;26(15):7617. doi: 10.3390/ijms26157617. Int J Mol Sci. 2025. PMID: 40806743 Free PMC article.
-
HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis.J Clin Med. 2021 Jul 6;10(14):3006. doi: 10.3390/jcm10143006. J Clin Med. 2021. PMID: 34300172 Free PMC article.
-
Association of ERAP2 polymorphisms in Colombian HLA-B27+ or HLA-B15+ patients with SpA and its relationship with clinical presentation: axial or peripheral predominance.RMD Open. 2020 Sep;6(2):e001250. doi: 10.1136/rmdopen-2020-001250. RMD Open. 2020. PMID: 32917832 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials